Abstract
Diarrhea, urgency, and fecal incontinence are common complaints in systemic mastocytosis and in patients with increased gastrointestinal mucosal mast cells. We performed anorectal manometry on six patients with clinical symptoms of mastocytosis and histologic evidence of increased mast cells and compared the results to anorectal manometry of six age-and sex-matched controls, with no bowel symptoms. Standard techniques with balloon volumes were used to measure maximal basal pressure, maximal squeeze pressure, smallest volume sensed, degree of relaxation of the internal sphincter, and the volume causing: (1) a strong urge to defecate and (2) pain. Patients with mastocytosis, compared with controls, had smaller balloon volumes induce rectal urgency (97 vs 164 ml) and pain (117 vs 278 ml). A trend was present for lower maximal basal pressure in mastocytosis, but was not statistically significant. Sensitivity to balloon inflation suggests decreased rectal compliance or overreactive rectal, contractility. These findings provide an explanation for the anorectal symptoms in patients with increased mast cells.
Similar content being viewed by others
References
Dvorak AM, Monahan RA: Crohn's disease-mast cell quantitation using one micron plastic sections for light microscopic study. Pathol Annu 18:181–190, 1983
Baum CA, Bhatia P, Miner PB: Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci 34:1462–1465, 1989
Stroble S, Busuttil A, Ferguson A: Human intestinal mucosal mast cells: Expanded population in untreated coeliac disease. Gut 24:222–227, 1983
Kosnai I, Kuitunen P, Savilahti E, Sipponen P: Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood. J Pediatr Gastroenterol Nutr 3:368–372, 1984
Matter S, Bhatia PS, Miner PB: Evaluation of antral mast cells in nonulcer dysplasia. Dig Dis Sci 35:1358–1363, 1990
Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD: Gastrointestinal function in systemic mastocytosis. Gastroenterology 95:657–667, 1988
Lindsley CB, Miner PB: Seronegative juvenile rheumatoid arthritis and mast cell-associated gastritis. Arthritis Rheum 34:106–109, 1991
Miner PB: The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis. J Invest Dermatol 96(suppl 3):40s-43s, 1991
Demis DJ: The mastocytosis syndrome. Ann Intern Med 59:194–206, 1963
Soter NA, Austen KF, Wasserman SI: Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301:465–469, 1979
Jarnum S, Zachariae H: Mastocytosis (urticaria pigmentosa) of skin, stomach, and gut with malabsorption. Gut 8:64–68, 1967
Konturek SJ, Siebers R: Role of histamine in myoelectric activity of the small bowel in the dog. Am J Physiol 238:50–56, 1980
Cooke HJ, Nemeth PR, Wood JD: Histamine action on guinea pig ileal mucosa. Am J Physiol 246:6372–6377, 1984
Burleigh DE, D'Mello A: Neural and pharmacologic factors effecting motility of the internal anal sphincter. Gastroenterology 84:409–417, 1983
Rao SSC, Read NW, Davison P, Bannister JJ, Haynes WG, Holdsworth CD: Anorectal function in ulcerative colitis. Gastroenterology 92:1589, 1987
Devroede G, Vobecky S, Masse S, Arhan P, Leger C: Ischemic fecal incontinence and rectal angina. Gastroenterology 83:970–980, 1982
Read NW: The neurotic bowel: A paradigm for the irritable bowel syndrome.In Irritable Bowel Syndrome. NW Read (ed). Oxford, Blackwell Scientific Publications, 1991, pp 1–15
Collins SM: Mast Cell interactions with smooth muscle and nerves in the gut: Speculation on mast cell modulation of gastrointestinal motility.In Irritable Bowel Syndrome. NW Read (ed). Oxford, Blackwell Scientific Publications, 1991, pp 159–173
Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin HS, Schuster MM: Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 98:1187–1192, 1990
Read NW, Harford WD, Schmulen AC, Read MG, SantaAna C, Fordtran JS: A clinical study of patients with fecal incontinence and diarrhea. Gastroenterology 76:747–756, 1979
Miner PB, Donnelly TC, Read NW: Investigation of mode of action of biofeedback in treatment of fecal incontinence. Dig Dis Sci 35:1291–1298, 1990
Wald AW: Biofeedback therapy for fecal incontinence. Ann Intern Med 95:146–149, 1981
Whorwell PJ, Mccallum M, Creed FH, Roberts CT: Noncolonic features of irritable bowel syndrome. Gut 27:37–40, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Libel, R., Biddle, W.L. & Miner, P.B. Evaluation of anorectal physiology in patients with increased mast cells. Digest Dis Sci 38, 877–881 (1993). https://doi.org/10.1007/BF01295914
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01295914